Cresset Asset Management’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,469
Closed -$213K 1964
2023
Q4
$213K Buy
+5,469
New +$177K ﹤0.01% 1673
2021
Q4
Sell
-7,649
Closed -$509K 1267
2021
Q3
$509K Sell
7,649
-4,312
-36% -$337K 0.01% 615
2021
Q2
$1.1M Sell
11,961
-675
-5% -$66.5K 0.02% 328
2021
Q1
$1.54M Buy
12,636
+5,120
+68% +$851K 0.02% 211
2020
Q4
$1.15M Buy
7,516
+900
+14% +$127K 0.02% 220
2020
Q3
$857K Buy
6,616
+2,190
+49% +$288K 0.02% 257
2020
Q2
$498K Buy
+4,426
New +$454K 0.01% 341
2020
Q1
Sell
-2,053
Closed -$208K 668
2019
Q4
$208K Buy
+2,053
New +$203K 0.01% 549
2019
Q2
Sell
-5
Closed -$1K 1378
2019
Q1
$1K Buy
+5
New +$561 ﹤0.01% 1847

Other funds holding PRLB

Cresset Asset Management's PRLB Position: Q1 2024 in Review

Cresset Asset Management sold out of Protolabs (PRLB) in Q1 2024, closing a stake of 5,469 shares — an estimated $213K sold.

Cresset Asset Management first reported a position in PRLB in Q1 2019 and held it in 9 quarters. The position peaked at $1.54M in Q1 2021. 203 funds tracked by Wall St. Rank hold PRLB as of Q1 2024.

  • Cresset Asset Management reported no remaining Protolabs position as of Q1 2024 after selling out during the quarter.
  • Cresset Asset Management sold 5,469 Protolabs shares in Q1 2024, an estimated $213K.
  • Cresset Asset Management first reported a position in Protolabs in Q1 2019 and held it in 9 quarters.
  • Cresset Asset Management's Protolabs position peaked at $1.54M in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Protolabs as of Q1 2024.

Based on Cresset Asset Management's 13F filing for Q1 2024, filed 15 May 2024.